PROFFERED PAPERS
Monday, March 22   —  8:00 AM   —  Virginia


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section F - Bone & Soft Tissue Pathology
Chaired By: Andrew Horvai and Andrew Rosenberg



TimeTitle and AuthorsItinerary
Planner
8:00 Lipomatous Neoplasms: The Diagnostic and Prognostic Implications of Molecular Classification (125)
H Zhang, ME Johnson, X Wang, AG Nascimento, FH Sim, R Zamolyi, V Pannain, AM Oliveira. - West China Hospital, Sichuan University, Chengdu, China; Mayo Clinic, Rochester; Universidade Federal do Rio de Janeiro, RJ, Brazil.
Add
8:15 Dedifferentiated Liposarcoma with "Homologous" Lipoblastic (Pleomorphic Liposarcoma-Like) Differentiation: Clinicopathologic and Molecular Analysis (93)
A Marino-Enriquez, CDM Fletcher, P Dal Cin, JL Hornick. - Brigham and Women's Hospital, Boston; Hospital Universitario La Paz, Madrid, Spain.
Add
8:30 Liposarcomas with Mixed Well-Differentiated and Pleomorphic Features — A Clinicopathologic Study of 8 Cases (54)
JM Boland, SW Weiss, AM Oliveira, ML Erickson-Johnson, AL Folpe. - Mayo Clinic, Rochester, MN; Emory University, Atlanta, GA.
Add
8:45 Dedifferentiated Liposarcoma with Inflammatory Myofibroblastic Differentiation (112)
A Shukla, DG Thomas, AJ Kubat, DR Lucas. - University of Michigan, Ann Arbor, MI; Spectrum Health, Grand Rapids, MI.
Add
9:00 Impact of Molecular Analysis on the Final Diagnosis of Sarcomas: A Study on 369 Cases Collected in the Setting of a European Epidemiological Study. A Report from CONTICANET Network of Excellence (63)
JM Coindre, AP Dei Tos, D Ranchere-Vince, MC Montesco, AV Decouveleare, L Toffolatti, F Chibon, I Hostein, D Pissaloux, L Alberti, PP Bringuier, E Lazzari, S Albert, C Bellera, JY Blay, CR Rossi. - Institut Bergonié, Bordeaux, France; Centre Léon Bérard, Lyon, France; General Hospital of Treviso, Treviso, Italy; University of Padua School of Medicine, Padua, Italy.
Add
9:15 Round Cell Inflammatory Myofibroblastic Tumor with Nuclear Membrane or Perinuclear ALK: An Aggressive Intra-Abdominal Variant (81)
JL Hornick, WL Wang, A Roy, D Lopez-Terrada, AJ Lazar, CM Coffin. - Brigham and Women's Hospital, Boston; UT-MD Anderson Cancer Center, Houston; Baylor College of Medicine, Houston; Vanderbilt University School of Medicine, Nashville.
Add
9:30 RECESS, EXHIBITS, POSTER SESSION I  
11:00 Adult Fibrosarcoma (FS): A Reevaluation of 154 Putative Cases Diagnosed at a Single Institution over a 48 Year Period (51)
A Bahrami, AL Folpe. - Mayo Clinic, Rochester, MN.
Add
11:15 The Prevalence of FUS Rearrangement in Sclerosing Epithelioid Fibrosarcoma (121)
W-L Wang, HL Evans, JM Meis, D Lopez-Terrada, AJ Lazar. - The University of Texas M.D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine/Texas Children's Hospital, Houston, TX.
Add
11:30 Low Grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma — A Clinicopathological Study of 15 Cases, Including Identification of 'Kinship' between These Two Sarcomas (106)
B Rekhi, M Deshmukh, NA Jambhekar. - Tata Memorial Centre, Mumbai, Maharashtra, India.
Add
11:45 Low-grade Fibromyxoid Sarcoma. A Clinicopathologic Study (76)
HL Evans. - UT M.D. Anderson Cancer Center, Houston, TX.
Add